Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Palma

Showing results (31-40 of 249) with videos related to

Pageof 25
Sort By:
Journal of Thoracic Disease|January 21, 2012
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversiesSuresh Senan, David A Palma, Frank J Lagerwaard
Seminars in Respiratory and Critical Care Medicine|May 26, 2020
Local Ablative Therapies in Oligometastatic NSCLC: New Data and New DirectionsPencilla Lang, Daniel R Gomez, David A Palma
Cancer|April 9, 2013
When randomized trials and observational data disagree: the case of preoperative versus postoperative chemoradiotherapy for esophageal cancerDavid A Palma, George B Rodrigues, Richard Malthaner
The Lancet. Oncology|November 2, 2013
Surgery versus SABR for NSCLCAlexander V Louie, Sasha Senthi, David A Palma
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2015
New Strategies in Stereotactic Radiotherapy for OligometastasesDavid A Palma, Alexander V Louie, George B Rodrigues
Journal of Neuro-Oncology|April 28, 2011
Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysisRobert A Olson, Priscilla K Brastianos, David A Palma
Cancer Journal (Sudbury, Mass.)|March 25, 2020
Radiation in the Treatment of Oligometastatic and Oligoprogressive Disease: Rationale, Recent Data, and Research QuestionsSondos Zayed, Rohann J M Correa, David A Palma
The British Journal of Radiology|June 2, 2016
Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?Sarah A Mattonen, Aaron D Ward, David A Palma
Radiation Oncology (London, England)|January 27, 2017
Intentional avoidance of the esophagus using intensity modulated radiation therapy to reduce dysphagia after palliative thoracic radiationPatrick V Granton, David A Palma, Alexander V Louie
International Journal of Radiation Oncology, Biology, Physics|August 2, 2016
In Reply to Sun et alSarah A Mattonen, Aaron D Ward, David A Palma
Pageof 25

Showing results (31-40 of 249) with videos related to

Sort By:
Pageof 25
Journal of Thoracic Disease|January 21, 2012
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversiesSuresh Senan, David A Palma, Frank J Lagerwaard
Seminars in Respiratory and Critical Care Medicine|May 26, 2020
Local Ablative Therapies in Oligometastatic NSCLC: New Data and New DirectionsPencilla Lang, Daniel R Gomez, David A Palma
Cancer|April 9, 2013
When randomized trials and observational data disagree: the case of preoperative versus postoperative chemoradiotherapy for esophageal cancerDavid A Palma, George B Rodrigues, Richard Malthaner
The Lancet. Oncology|November 2, 2013
Surgery versus SABR for NSCLCAlexander V Louie, Sasha Senthi, David A Palma
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2015
New Strategies in Stereotactic Radiotherapy for OligometastasesDavid A Palma, Alexander V Louie, George B Rodrigues
Journal of Neuro-Oncology|April 28, 2011
Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysisRobert A Olson, Priscilla K Brastianos, David A Palma
Cancer Journal (Sudbury, Mass.)|March 25, 2020
Radiation in the Treatment of Oligometastatic and Oligoprogressive Disease: Rationale, Recent Data, and Research QuestionsSondos Zayed, Rohann J M Correa, David A Palma
The British Journal of Radiology|June 2, 2016
Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?Sarah A Mattonen, Aaron D Ward, David A Palma
Radiation Oncology (London, England)|January 27, 2017
Intentional avoidance of the esophagus using intensity modulated radiation therapy to reduce dysphagia after palliative thoracic radiationPatrick V Granton, David A Palma, Alexander V Louie
International Journal of Radiation Oncology, Biology, Physics|August 2, 2016
In Reply to Sun et alSarah A Mattonen, Aaron D Ward, David A Palma
Pageof 25